5.485

2.20% -0.115

Precigen Inc (PGEN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$5.60

Aprire:

$5.63

Volume 24 ore:

5.92M

Relative Volume:

1.34

Capitalizzazione di mercato:

$1.96B

Reddito:

$9.68M

Utile/perdita netta:

$-250.64M

Rapporto P/E:

-3.9184

EPS:

-1.3998

Flusso di cassa netto:

$-89.83M

1 W Prestazione:

-3.91%

1M Prestazione:

+52.99%

6M Prestazione:

+12.93%

1 anno Prestazione:

+244.46%

Intervallo 1D:

$5.43

$5.795

Intervallo di 1 settimana:

$5.20

$5.795

Portata 52W:

$1.47

$6.04

Precigen Inc Stock (PGEN) Company Profile

Nome

Precigen Inc

Settore

Healthcare (1100)

Industria

Biotechnology (615)

Telefono

301-556-9900

Indirizzo

20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD

Dipendente

Cinguettio

@precigen

Prossima data di guadagno

2026-08-11

Ultimi documenti SEC

PGEN's Discussions on Twitter

Compare PGEN vs VRTX, REGN, ARGX, ALNY, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
PGEN Precigen Inc	5.485	2.00B	9.68M	-250.64M	-89.83M	-1.3998
VRTX Vertex Pharmaceuticals Inc	524.42	134.41B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	677.05	68.13B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	920.56	57.01B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	321.38	41.79B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	190.47	40.39B	742.00K	-1.37B	-1.07B	-7.0731

Precigen Inc Stock (PGEN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-08-15	Aggiornamento	JP Morgan	Underweight → Neutral
2024-03-22	Downgrade	JP Morgan	Neutral → Underweight
2023-05-23	Iniziato	JP Morgan	Neutral
2022-11-18	Iniziato	Cantor Fitzgerald	Overweight
2021-02-25	Iniziato	Stifel	Buy
2021-02-22	Iniziato	Wells Fargo	Overweight
2021-02-18	Iniziato	B. Riley Securities	Buy
2020-05-08	Iniziato	H.C. Wainwright	Buy

Mostra tutto

Precigen Inc Borsa (PGEN) Ultime notizie

Jul 05, 2026

Precigen reports $3.4M in PAPZIMEOS sales for Q4 2025 - Investing.com

Jul 05, 2026

Jul 03, 2026

PGENPrecigen Inc Latest SEC Filings - Finviz

Jul 03, 2026

Jul 02, 2026

Precigen Insider Sold Shares Worth $2,042,864, According to a Recent SEC Filing - marketscreener.com

Jul 02, 2026

Precigen Insider Sold Shares Worth $1,113,143, According to a Recent SEC Filing - Moomoo

Jul 02, 2026

Jul 01, 2026

Precigen CFO Harry Thomasian Jr. sells $1.1m in company stock - Investing.com UK

Jul 01, 2026

Precigen COO Rutul Shah sells $251,105 in company stock By Investing.com - Investing.com South Africa

Jul 01, 2026

Precigen CEO Helen Sabzevari sells $2.04m in PGEN stock By Investing.com - Investing.com India

Jul 01, 2026

[Form 4] PRECIGEN, INC. Insider Trading Activity - Stock Titan

Jul 01, 2026

Form 4 Precigen Inc For: 1 July By Investing.com - Investing.com Canada

Jul 01, 2026

Precigen (PGEN) CFO executes 200,000-share open-market sale under 10b5-1 plan - Stock Titan

Jul 01, 2026

Form 144 PRECIGEN For: 1 July By Investing.com - Investing.com Nigeria

Jul 01, 2026

PGEN (NASDAQ) affiliate files Rule 144 notice to sell 28,571 shares - Stock Titan

Jul 01, 2026

Does Precigen’s (PGEN) Russell Value Index Exit Signal a Shifting Investor Base or Story? - simplywall.st

Jul 01, 2026

Jun 29, 2026

[144] PRECIGEN, INC. SEC Filing - Stock Titan

Jun 29, 2026

Form 144 PRECIGEN For: 29 June By Investing.com - Investing.com South Africa

Jun 29, 2026

Precigen, Inc.(NasdaqGS: PGEN) dropped from Russell 2000 Value Benchmark - marketscreener.com

Jun 29, 2026

Precigen, Inc.(NasdaqGS: PGEN) dropped from Russell Microcap Value Benchmark Index - marketscreener.com

Jun 29, 2026

Jun 28, 2026

Precigen, Inc.(NasdaqGS: PGEN) dropped from Russell 2500 Value Benchmark - marketscreener.com

Jun 28, 2026

Precigen, Inc.(NasdaqGS: PGEN) dropped from Russell 3000E Value Benchmark - marketscreener.com

Jun 28, 2026

Jun 26, 2026

Precigen: Entering The Oncology "Sweet Spot" (NASDAQ:PGEN) - Seeking Alpha

Jun 26, 2026

PGEN Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026

Jun 25, 2026

Price to sales forward of Precigen, Inc. – NASDAQ:PGEN - TradingView

Jun 25, 2026

Precigen Inc Actuals & Estimates (BX:I5X) - TradingView

Jun 25, 2026

Price to earnings forward of Precigen, Inc. – NASDAQ:PGEN - TradingView

Jun 25, 2026

Precigen Shareholders Expand Incentive Plan, Reaffirm Governance - The Globe and Mail

Jun 25, 2026

Jun 24, 2026

Precigen (PGEN) investors back 7M-share incentive pool and all board picks - Stock Titan

Jun 24, 2026

Clearfield And 2 Insider Picks For Strong Growth - simplywall.st

Jun 24, 2026

Precigen (PGEN) Is Up 12.1% After Orphan Exclusivity Win for PAPZIMEOS TherapyWhat's Changed - Sahm

Jun 24, 2026

Jun 23, 2026

Precigen stock hits 52-week high at 5.47 USD By Investing.com - Investing.com Australia

Jun 23, 2026

Precigen stock hits 52-week high at 5.47 USD - Investing.com

Jun 23, 2026

Jun 22, 2026

Precigen (PGEN) Ends 11.6% Higher — This FDA Approval Could Hold the Reason - Insider Monkey

Jun 22, 2026

Precigen Gains FDA Orphan Drug Exclusivity for Gene Therapy Candidate PAPZIMEOSDebt Analysis Report - Město Břeclav

Jun 22, 2026

Jun 20, 2026

Precigen (PGEN) Secures FDA Orphan Drug Exclusivity for PAPZIMEOS - Insider Monkey

Jun 20, 2026

Jun 18, 2026

PGEN News | PRECIGEN INC (NASDAQ:PGEN) - ChartMill

Jun 18, 2026